PrecisionLife
corporateWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Relevant strategic financing or commercial partner because the evidence says it partners with biopharma companies and technology/data providers. OpenDrugs is building evidence-backed compound, target, pathway, and single-cell infrastructure that could fit a partnership-oriented precision medicine ecosystem.